Hijacking of the AP-1 Signaling Pathway during Development of ATL
- PMID: 29379481
- PMCID: PMC5775265
- DOI: 10.3389/fmicb.2017.02686
Hijacking of the AP-1 Signaling Pathway during Development of ATL
Abstract
Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of a fatal malignancy known as adult T-cell leukemia (ATL). One way to address the pathology of the disease lies on conducting research with a molecular approach. In addition to the analysis of ATL-relevant signaling pathways, understanding the regulation of important and relevant transcription factors allows researchers to reach this fundamental objective. HTLV-1 encodes for two oncoproteins, Tax and HTLV-1 basic leucine-zipper factor, which play significant roles in the cellular transformation and the activation of the host's immune responses. Activating protein-1 (AP-1) transcription factor has been linked to cancer and neoplastic transformation ever since the first representative members of the Jun and Fos gene family were cloned and shown to be cellular homologs of viral oncogenes. AP-1 is a dimeric transcription factor composed of proteins belonging to the Jun (c-Jun, JunB, and JunD), Fos (c-Fos, FosB, Fra1, and Fra2), and activating transcription factor protein families. Activation of AP-1 transcription factor family by different stimuli, such as inflammatory cytokines, stress inducers, or pathogens, results in innate and adaptive immunity. AP-1 is also involved in various cellular events including differentiation, proliferation, survival, and apoptosis. Deregulated expression of AP-1 transcription factors is implicated in various lymphomas such as classical Hodgkin lymphomas, anaplastic large cell lymphomas, diffuse large B-cell lymphomas, and adult T-cell leukemia. Here, we review the current thinking behind deregulation of the AP-1 pathway and its contribution to HTLV-induced cellular transformation.
Keywords: AP-1; HBZ; HTLV-1; JunD; antisense transcription; leukemia.
Figures
Similar articles
-
Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms.Clin Exp Med. 2017 Aug;17(3):291-304. doi: 10.1007/s10238-016-0436-z. Epub 2016 Sep 6. Clin Exp Med. 2017. PMID: 27600282 Review.
-
HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein.Oncogene. 2005 Feb 3;24(6):1001-10. doi: 10.1038/sj.onc.1208297. Oncogene. 2005. PMID: 15592508
-
Modulation of nuclear factor-ϰB by human T cell leukemia virus type 1 tax protein : Implications for oncogenesis and inflammation.Immunol Res. 2006 Jan;34(1):1-12. doi: 10.1385/IR:34:1:1. Immunol Res. 2006. PMID: 27519575
-
Human T-cell leukemia virus type 1 tax transactivates the matrix metalloproteinase 7 gene via JunD/AP-1 signaling.Biochim Biophys Acta. 2011 May;1813(5):731-41. doi: 10.1016/j.bbamcr.2011.02.002. Epub 2011 Feb 18. Biochim Biophys Acta. 2011. PMID: 21315773
-
Modulation of nuclear factor-kappaB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation.Immunol Res. 2006;34(1):1-12. Immunol Res. 2006. PMID: 16720895 Review.
Cited by
-
KSHV promotes oncogenic FOS to inhibit nuclease AEN and transactivate RGS2 for AKT phosphorylation.bioRxiv [Preprint]. 2024 Jan 28:2024.01.27.577582. doi: 10.1101/2024.01.27.577582. bioRxiv. 2024. PMID: 38410462 Free PMC article. Preprint.
-
The dengue-specific immune response and antibody identification with machine learning.NPJ Vaccines. 2024 Jan 20;9(1):16. doi: 10.1038/s41541-023-00788-7. NPJ Vaccines. 2024. PMID: 38245547 Free PMC article.
-
Identification of genes associated with gall bladder cell carcinogenesis: Implications in targeted therapy of gall bladder cancer.World J Gastrointest Oncol. 2023 Dec 15;15(12):2053-2063. doi: 10.4251/wjgo.v15.i12.2053. World J Gastrointest Oncol. 2023. PMID: 38173427 Free PMC article. Review.
-
Role of Fra-2 in cancer.Cell Death Differ. 2024 Feb;31(2):136-149. doi: 10.1038/s41418-023-01248-4. Epub 2023 Dec 16. Cell Death Differ. 2024. PMID: 38104183 Free PMC article. Review.
-
Heterogeneity in the Metastatic Microenvironment: JunB-Expressing Microglia Cells as Potential Drivers of Melanoma Brain Metastasis Progression.Cancers (Basel). 2023 Oct 13;15(20):4979. doi: 10.3390/cancers15204979. Cancers (Basel). 2023. PMID: 37894348 Free PMC article.
References
-
- Abate C., Curran T. (1990). Encounters with Fos and Jun on the road to AP-1. Semin. Cancer Biol. 1 19–26. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
